- Home
- CVAC vs MVST Comparison
CVAC vs MVST Comparison
Compare CVAC & MVST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVAC
- MVST
- Stock Information
- Founded
- CVAC 2000
- MVST 2006
- Country
- CVAC Germany
- MVST United States
- Employees
- CVAC N/A
- MVST N/A
- Industry
- CVAC Biotechnology: Pharmaceutical Preparations
- MVST Industrial Machinery/Components
- Sector
- CVAC Health Care
- MVST Miscellaneous
- Exchange
- CVAC Nasdaq
- MVST Nasdaq
- Market Cap
- CVAC 818.8M
- MVST 676.9M
- IPO Year
- CVAC 2020
- MVST N/A
- Fundamental
- Price
- CVAC $3.30
- MVST $1.95
- Analyst Decision
- CVAC Hold
- MVST Buy
- Analyst Count
- CVAC 3
- MVST 3
- Target Price
- CVAC $10.00
- MVST $3.33
- AVG Volume (30 Days)
- CVAC 617.5K
- MVST 7.6M
- Earning Date
- CVAC 11-12-2024
- MVST 03-31-2025
- Dividend Yield
- CVAC N/A
- MVST N/A
- EPS Growth
- CVAC N/A
- MVST N/A
- EPS
- CVAC N/A
- MVST N/A
- Revenue
- CVAC $70,565,734.00
- MVST $370,989,000.00
- Revenue This Year
- CVAC $742.57
- MVST $19.19
- Revenue Next Year
- CVAC N/A
- MVST $29.35
- P/E Ratio
- CVAC N/A
- MVST N/A
- Revenue Growth
- CVAC 75.11
- MVST 39.03
- 52 Week Low
- CVAC $2.22
- MVST $0.15
- 52 Week High
- CVAC $5.28
- MVST $2.87
- Technical
- Relative Strength Index (RSI)
- CVAC 39.12
- MVST 51.31
- Support Level
- CVAC $3.53
- MVST $1.55
- Resistance Level
- CVAC $3.72
- MVST $2.42
- Average True Range (ATR)
- CVAC 0.18
- MVST 0.20
- MACD
- CVAC -0.06
- MVST 0.03
- Stochastic Oscillator
- CVAC 10.96
- MVST 55.24
About CVAC CureVac N.V.
CureVac is a biopharmaceutical company headquartered in Germany that is developing vaccines and therapies using messenger ribonucleic acid, or mRNA. The company was founded in 2000 and had its initial public offering in August 2020. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and Covid vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.
About MVST Microvast Holdings Inc.
Microvast Holdings Inc is a technology innovator that designs, develops, and manufactures lithium-ion battery solutions. It is renowned for its cutting-edge cell technology and its vertical integration capabilities which extend from core battery chemistry to battery packs.